Home
>
National Drug Code (NDC)
>
Cisatracurium Besylate
Cisatracurium Besylate - 25021-669-20 - (cisatracurium besylate)
Drug Information of Cisatracurium Besylate
| Product NDC: | 25021-669 |
| Proprietary Name: | Cisatracurium Besylate |
| Non Proprietary Name: | cisatracurium besylate |
| Active Ingredient(s): | 10 mg/mL & nbsp; cisatracurium besylate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cisatracurium Besylate
| Product NDC: | 25021-669 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA201836 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120927 |
Package Information of Cisatracurium Besylate
| Package NDC: | 25021-669-20 |
| Package Description: | 1 VIAL in 1 CARTON (25021-669-20) > 20 mL in 1 VIAL |
NDC Information of Cisatracurium Besylate
| NDC Code | 25021-669-20 |
| Proprietary Name | Cisatracurium Besylate |
| Package Description | 1 VIAL in 1 CARTON (25021-669-20) > 20 mL in 1 VIAL |
| Product NDC | 25021-669 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cisatracurium besylate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120927 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | CISATRACURIUM BESYLATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
